Example: Heart Attack

Clinical Trials on Atrophy

Total 745 results

NCT03520179

Recruiting

Improving Standards of Care and Translational Research in Spinal Muscular Atrophy (SMA)

Conditions: Spinal Muscular Atrophy
NCT04940702

Not yet recruiting

Effectiveness of Focal Vibration and Blood Flow Restriction Within a Multicomponent Exercise Programme.

Conditions: Sarcopenia, Occlusion, Vibration; Exposure, Old Age; Atrophy, Exercise Addiction
NCT03972709

Recruiting

A Study Assessing the Safety, Tolerability, and Efficacy of RG6147 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Conditions: Macular Degeneration, Age-Related, Geographic Atrophy
NCT02132052

Completed

Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Basal Degeneration (CBD), Multiple Systems Atrophy (MSA), Magnetoencephalography.

Conditions: Essential Tremor, Multiple System Atrophy, Corticobasal Degeneration, Supranuclear Palsy, Progressive, Parkinson Disease
NCT03846193

Recruiting

FocuS: First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD

Conditions: Dry Age-related Macular Degeneration, Macular Degeneration, Retinal Disease, Eye Diseases, Retinal Degeneration, Geographic Atrophy, Macular Atrophy
NCT00029965

Recruiting

Natural History of Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders

Conditions: Neurological Regression, Myoclonus, Cherry Red Spot, Brain Atrophy
NCT03696576

Terminated

Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy

Conditions: Voice Disorder, Vocal Cord Atrophy, Presbyphonia
NCT04488133

Recruiting

A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec

Conditions: Muscular Atrophy, Spinal
NCT04809714

Not yet recruiting

The Role of Blood Flow Restriction Therapy in Postoperative Elderly Patients With Hip Fracture

Conditions: Hip Fractures, Muscle Atrophy
NCT02908685

Active, not recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Conditions: Muscular Atrophy, Spinal
NCT03525613

Active, not recruiting

A Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Conditions: Geographic Atrophy
NCT03525600

Active, not recruiting

Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Conditions: Geographic Atrophy
NCT04607707

Completed

Women's Satisfaction and Adherence to Vulvovaginal Atrophy Treatments

Conditions: Vulvovaginal Atrophy
NCT04932122

Not yet recruiting

Outcomes After Dorsal Wrist Ganglia Excision With or Without PIN

Conditions: Wrist Ganglion, Ganglion Cysts, Hand Ganglion, Denervation Atrophy
NCT03921528

Active, not recruiting

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy

Conditions: Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3, Spinal Muscular Atrophy Type 2, SMA, Neuromuscular Diseases, Muscular Atrophy, Atrophy, Muscular Atrophy, Spinal, Neuromuscular Manifestations
NCT03647189

Completed

Randomized, Controlled Trial With Hybrid Fractional Laser

Conditions: Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia
NCT04676854

Recruiting

Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD

Conditions: Geographic Atrophy
NCT04718181

Recruiting

Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants

Conditions: Muscular Atrophy, Spinal
NCT04925622

Recruiting

Complex Eye Movements in Parkinson's Disease and Related Movement Disorders

Conditions: Parkinson Disease, Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy, Corticobasal Degeneration, Parkinsonian Disorders, Essential Tremor, Vascular Parkinsonism, Multiple System Atrophy, Parkinson Variant, Parkinsonian Syndrome
NCT02327845

Enrolling by invitation

Phenotype, Genotype & Biomarkers in ALS and Related Disorders

Conditions: Amyotrophic Lateral Sclerosis, Frontotemporal Dementia, Primary Lateral Sclerosis, Hereditary Spastic Paraplegia, Progressive Muscular Atrophy, Multisystem Proteinopathy
NCT03306277

Completed

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

Conditions: SMA - Spinal Muscular Atrophy, Gene Therapy
NCT02122952

Completed

Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1

Conditions: Spinal Muscular Atrophy 1
NCT04607148

Recruiting

A Study Assessing the Long-Term Safety and Tolerability of RG6147 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Conditions: Macular Degeneration, Age-Related, Geographic Atrophy
NCT03815825

Recruiting

GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Conditions: Macular Degeneration, Geographic Atrophy
NCT04907162

Recruiting

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Conditions: Pompe Disease (Late-onset), Myotonic Dystrophy Type 1 (DM1), Myotonic Dystrophy Type 2, Spinal Muscular Atrophy Type 3, Inclusion Body Myositis, Sporadic, Facioscapulohumeral Muscular Dystrophy 1, Healthy